Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_E58177EB207A isbn:1526-632X[electronic], 0028-3878[linking] pmid:20404315 doi:10.1212/WNL.0b013e3181d8a5ed isiid:000276816200017 |
| Idioma(s) |
en |
| Fonte |
Neurology, vol. 74, no. 16, pp. 1329 |
| Palavras-Chave | #Anticonvulsants/pharmacology; Anticonvulsants/therapeutic use; Antineoplastic Agents/agonists; Antineoplastic Agents/blood; Bias (Epidemiology); Brain Neoplasms/drug therapy; Brain Neoplasms/mortality; Clinical Trials as Topic; Drug Interactions/physiology; Enzyme Activation/drug effects; Enzyme Activation/physiology; Enzymes/drug effects; Enzymes/metabolism; Glioblastoma/drug therapy; Glioblastoma/mortality; Humans; Meta-Analysis as Topic; Reproducibility of Results; Survival Rate; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
